The effect of simvastatin on panel-reactive antibody and crossmatch positivity.
Ozdemir
F N
FN
Başkent University Faculty of Medicine, Department of Nephrology, Ankara, Turkey.
Sezer
S
S
Turan
M
M
Colak
T
T
Arat
Z
Z
Gülmüş
S
S
Haberal
M
M
D000328:Adult; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D005190:Family; D005260:Female; D005434:Flow Cytometry; D006650:Histocompatibility Testing; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D010956:Plasmapheresis; D019821:Simvastatin / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014019:Tissue Donors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D016572:Cyclosporine; D019821:Simvastatin